Stress ulcer prophylaxis in mechanically ventilated patients: integrating evidence and judgment using a decision analysis
- First Online:
- 360 Downloads
Stress ulcer prophylaxis with a histamine-2 receptor antagonist can reduce the risk of gastrointestinal bleeding in mechanically ventilated patients but may also increase the risk of ventilator-associated pneumonia. We sought to clarify the tradeoffs involved in selecting a prophylactic strategy.
Patients and participants
A decision tree was constructed for a hypothetical cohort of patients receiving mechanical ventilation for an expected duration of longer than 48 h, using probabilities estimated from the published literature.
Patients in the model could receive either prophylaxis with a histamine-2 receptor antagonist or no prophylaxis. Sensitivity analyses were preformed varying the estimated probabilities over their plausible ranges.
Measurements and results
Both strategies were associated with approximately the same baseline expected mortality (16.6% for histamine-2 receptor antagonists and 16.9% for no prophylaxis, risk difference 0.3%). Varying the estimated probabilities resulted in only small changes in both the expected mortality and the absolute risk reduction associated with the preferred treatment. At the extremes of assumptions the absolute mortality reduction ranged from 0.1% to 3.3%.
No single strategy of stress ulcer prophylaxis is preferred when mortality is used as the outcome. In the absence of a clinical trial demonstrating survival benefit the individual clinician's assumptions regarding the effect of prophylaxis on gastrointestinal bleeding and pneumonia and the attributable mortality of pneumonia vs. gastrointestinal bleeding will have a significant effect on the decision.
KeywordsCritical care Intensive care Gastrointestinal hemorrhage Pneumonia Nosocomial infections
- 10.Hubmayr RD, Burchardi H, Elliot M, Fessler H, Georgopoulos D, Jubran A, Limper A, Pesenti A, Rubenfeld G, Stewart T, Villar J (2002) Statement of the 4th International Consensus Conference in Critical Care on ICU-Acquired Pneumonia-Chicago, Illinois, May 2002. Intensive Care Med 28:1521–1536PubMedCrossRefGoogle Scholar
- 13.Dressler DD, Williams MV, Rask KM (2001) Prevention of clinically significant gastrointenstinal bleeding in intensive care unit patients. In: Shojania KG, Duncan BW, McDonald KM, Wachter RM (eds) Making health care safer: a critical analysis of patient safety practices. Agency for Healthcare Research and Quality, RockvilleGoogle Scholar
- 15.Anonymous (2004) Ventilator bundle (IHI tool). BMJ available at: http://www.ihi.org, accessed 10 March 2005Google Scholar
- 16.Joint Commission on Accreditation of Healthcare Organizations (2005) Specifications manual for national hospital quality measures, ICU, version 1.0Google Scholar
- 18.Ruiz-Santana S, Ortiz E, Gonzalez B, Bolanos J, Ruiz-Santana AJ, Manzano JL (1991) Stress-induced gastroduodenal lesions and total parenteral nutrition in critically ill patients: frequency, complications, and the value of prophylactic treatment. A prospective, randomized study. Crit Care Med 19:887–891PubMedCrossRefGoogle Scholar
- 19.Cook D, Guyatt G, Marshall J, Leasa D, Fuller H, Hall R, Peters S, Rutledge F, Griffith L, McLellan A, Wood G, Kirby A (1998) A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med 338:791–797PubMedCrossRefGoogle Scholar
- 22.Conrad SA, Gabrielli A, Margolis B, Quartin A, Hata JS, Frank WO, Bagin RG, Rock JA, Hepburn B, Laine L (2005) Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med 33:760–765PubMedCrossRefGoogle Scholar
- 39.Markowicz P, Wolff M, Djedaini K, Cohen Y, Chastre J, Delclaux C, Merrer J, Herman B, Veber B, Fontaine A, Dreyfuss D (2000) Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Incidence, prognosis, and risk factors. ARDS Study Group. Am J Respir Crit Care Med 161:1942–1948PubMedGoogle Scholar